Related Experiment Videos
[Cardiac hypertrophy: molecular and cellular events].
Juan Eduardo Carreño1, Felipe Apablaza, María Paz Ocaranza
1Laboratorio de Cardiología Molecular, Departamento de Enfermedades Cardiovasculares, Escuela de Medicina, Pontificia Universidad Católica de Chile, Lira 85, piso 2, Santiago, Chile.
Revista Espanola De Cardiologia
|June 6, 2006
Summary
Cardiac hypertrophy is a cardiomyocyte response to stress that can lead to heart failure. Understanding its molecular basis, including gene expression changes, is key to developing new treatments.
Area of Science:
- Cardiology and Molecular Biology
- Investigates cellular and molecular mechanisms underlying cardiac adaptation.
Context:
- Cardiac hypertrophy is a cardiomyocyte response to mechanical and neurohormonal stimuli.
- While initially compensatory, it can lead to heart failure, a condition with high morbidity and mortality.
Purpose:
- To provide a schematic overview of the molecular pathogenesis of cardiomyocyte hypertrophy.
- Emphasizes new research topics and investigations in this field.
Summary:
- Cardiac hypertrophy involves complex molecular pathways, including membrane receptors, second messengers, and transcription factors.
- Gene expression variations, particularly the re-expression of fetal genes, serve as a molecular marker for pathologic hypertrophy.
- This genetic response differs from normal physiologic cardiac growth.
Impact:
- Understanding molecular pathogenesis is crucial for developing strategies to halt or reverse pathologic cardiac hypertrophy.
- This research aims to slow the progression of heart failure, a significant clinical challenge.